嘉应制药(002198) - 2020 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2020 was CNY 92,384,827.51, an increase of 5.26% compared to CNY 87,770,964.01 in the same period last year[7] - Net profit attributable to shareholders decreased by 80.25% to CNY 1,674,030.75 from CNY 8,477,275.40 year-on-year[7] - Net profit excluding non-recurring items fell by 69.46% to CNY 2,540,317.24 compared to CNY 8,317,203.89 in the previous year[7] - Basic earnings per share fell by 0.01 yuan, a decrease of 80.25%, attributed to a decline in net profit[15] - The total comprehensive income for the current period was CNY -898,960.27, compared to CNY -2,591,069.87 in the previous period[46] Cash Flow and Liquidity - Operating cash flow improved by 31.88%, with a net cash flow of CNY -19,651,242.63, compared to CNY -28,848,233.85 in the same period last year[7] - Cash received from other operating activities decreased by 1.3313 million yuan, a drop of 65.82%, mainly due to reduced external receivables[16] - Cash paid for purchasing goods and services increased by 20.5807 million yuan, a rise of 95.09%, primarily due to higher payments for raw material purchases[17] - The cash flow from operating activities showed a net outflow of CNY -19,651,242.63, an improvement from CNY -28,848,233.85 in the previous period[49] - The company experienced a net decrease in cash and cash equivalents of -15,072,570.53 yuan, compared to -9,831,258.04 yuan in the previous period, indicating ongoing liquidity challenges[53] Assets and Liabilities - Total assets at the end of the reporting period were CNY 822,180,050.40, a decrease of 3.94% from CNY 855,938,235.21 at the end of the previous year[7] - Total liabilities amounted to CNY 125,567,053.44, down from CNY 131,305,560.61 in the previous period[37] - The company reported a decrease in inventory to CNY 51,766,153.15 from CNY 52,688,556.92[36] - The company’s short-term borrowings increased to CNY 90,000,000.00 from CNY 51,781,065.63[36] Operating Costs and Expenses - Operating costs increased by 8.2362 million yuan, a growth of 32.71%, mainly due to rising raw material and labor costs[15] - Financial expenses rose by 943,000 yuan, an increase of 416.05%, primarily due to higher interest payments on short-term bank loans[15] - Other operating income decreased by 1.8497 million yuan, a decline of 99.55%, mainly due to reduced government subsidies received during the period[15] - The company incurred sales expenses of CNY 6,798,616.82, significantly higher than CNY 1,870,137.51 in the previous period[44] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 38,684[10] Financial Reporting and Standards - The company did not execute the new revenue and leasing standards for the first quarter of 2020, indicating a stable accounting approach[54] - The first quarter report was not audited, which may affect the reliability of the financial data presented[55]